ModerateCardiovascularHeart failure with reduced ejection fractionuk-plab-1
A 68-year-old man with a history of hypertension and previous myocardial infarction presents with breathlessness and ankle swelling. Echocardiography shows a left ventricular ejection fraction of 30%. He is already on an ACE inhibitor at target dose. According to NICE guidance, which additional drug class should be introduced as part of foundational therapy for heart failure with reduced ejection fraction?